Thierry Roger

Has grant

Associate Professor

Université de Lausanne Faculté de biologie et de médecine

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thierry Roger is an Associate Professor at Université de Lausanne Faculté de biologie et médecine in Switzerland. His research areas include immunotherapy in sepsis, the role of myeloid-derived suppressor cells in critically ill patients, and the effects of metabolic responses in infection contexts. He has authored several significant articles focusing on the implications of weight loss in preclinical studies and the interactions of immune cells during severe health challenges.

Recent Grants

Grant: Close

ImmunoSep. Personalized immuno-therapy in sepsis: a precision medicine based approach

Open Date: 2020-01-01

Close Date: 2024-01-01

Grant: Close

Host-Directed Medicine in invasive FUNgal infections

Open Date: 2020-01-01

Close Date: 2024-01-01

Grant: Close

Metabosep: Understanding and harnessing the scope of metabolic perturbation in Sepsis

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Development of theranostics tools for precision medicine approaches in sepsis using high-dimensional immune phenotyping analyses by flow and mass cytometry

Open Date: 2020-01-01

Close Date: 2021-01-01

Grant: Close

Personalized Swiss Sepsis Study

Open Date: 2018-01-01

Close Date:

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Mihai G. Netea

Radboud University Medical Center

NETHERLANDS

View details

Françoise PORTEU

INSERM

FRANCE

View details

Dominik J. Schaer

Professor of General Internal Medicine

University of Zurich

SWITZERLAND

View details

Francois Delhommeau

Head

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

Lokesh Sharma

Assistant Professor

Yale University

UNITED STATES

View details

Thierry Calandra

Lausanne University Hospital

SWITZERLAND

View details

A Antoniadou

National and Kapodistrian University of Athens

GREECE

View details

Matthijs Kox

Radboud University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thierry Roger

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients

Using weight loss to predict outcome and define a humane endpoint in preclinical sepsis studies

Author Correction: Using weight loss to predict outcome and define a humane endpoint in preclinical sepsis studies

Towards personalized medicine: a scoping review of immunotherapy in sepsis

Editorial: Beneficial and pathological roles of myeloid cells during COVID-19.

Author Correction: Transmission of trained immunity and heterologous resistance to infections across generations.

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.

Dysregulated monocyte-derived macrophage response to Group B Streptococcus in newborns

COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.

Butyrate Supplementation Exacerbates Myocardial and Immune Cell Mitochondrial Dysfunction in a Rat Model of Faecal Peritonitis

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure

Stapled Porcine Pericardium Displays Lower Infectivity In Vitro Than Native and Sutured Porcine Pericardium

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes

Reply to: 'Lack of evidence for intergenerational inheritance of immune resistance to infections'.

COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Collaborators (8)

Mihai G. Netea

Françoise PORTEU

Dominik J. Schaer

Francois Delhommeau

Lokesh Sharma

Thierry Calandra

A Antoniadou

Matthijs Kox

Make your next move.